Urticaria after topical immunotherapy with diphenylcyclopropenone

Contact Dermatitis

Volumn 47, Issue 5, 2002, Pages 310-311

  Francomano, M ^a   Seidenari, Stefania ^a,b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Department of Dermatology ^*  (Italy)

Author keywords

Alopecia areata; Diphenylcyclopropenone; Topical immunotherapy; Urticaria

Indexed keywords

DIPHENCYPRONE;

ADOLESCENT; ADULT; ALOPECIA AREATA; ARTICLE; CASE REPORT; CONTACT URTICARIA; ERYTHEMA MULTIFORME; FEMALE; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; IMMUNOTHERAPY; MALE; PATHOGENESIS; PSORIASIS; URTICARIA; VITILIGO;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; ALOPECIA AREATA; CYCLOPROPANES; DIAGNOSIS, DIFFERENTIAL; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; IMMUNOTHERAPY; MALE; URTICARIA;

EID: 0036877376     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0536.2002.4705102.x     Document Type: Article

References (18)

1. Happle R, Hausen B M, Wiesner-Menzel L. Diphencyprone in the treatment of alopecia areata. Acta Dermatovener (Stockholm) 1983: 63: 49-52.
2. Orecchia G, Marelli M A, Perfetti L, Rabbiosi G. Alopecia areata: more on topical sensitizer. Dermatologica 1990: 180: 57-59.
3. Madani S, Shapiro J. Alopecia areata update. J Am Acad Dermatol 2000: 42: 549-566.
4. Happle R. Antigenic competition as a therapeutic concept for alopecia areata. Arch Dermatol Res 1980: 267: 109-114.
5. Buckely D A, Du Vivier A W P. Topical immunotherapy in dermatology. IJCP 1999: 53: 130-137.
6. Goldsmith L. Summary of alopecia areata research workshop and future research directions. J Invest Dermatol 1991: 96: 98S-100S.
7. Hoffmann R. The potential role of cytokine and T cells in alopecia areata. J Invest Dermatol Symp Proceedings 1999: 4: 235-238.
8. Bodemer C, Peuchmaur M, Fraitaig S, Chatenoud L, Brousse N, de Prost Y. Role of cytotoxic T cells in chronic alopecia areata. J Invest Dermatol 2000: 114: 112-116.
9. Happle R, Klein H M, Macher E. Topical immunotherapy changes the composition of the peribulbar infiltrate in alopecia areata. Arch Dermatol Res 1986: 278: 214-218.
10. Monk B. Induction of hair growth in alopecia totalis with diphencyprone sensitization. Clin Exp Dermatol 1989: 14: 154-157.
11. van der Steen Ph M, van Baar H M J, Perret C M, Happle R. Treatment of alopecia areata with diphenylcyclopropenone. J Am Acad Dermatol 1991: 24: 253-257.
12. Berth-Jones J, Hutchinson P E. Treatment of alopecia totalis with a combination of inosine pranobex and diphencyprone compared to each treatment alone. Clin Exp Dermatol 1991: 16: 172-175.
13. Alam M, Gross E A, Savin R C. Severe urticarial reaction to diphenylcyclopropenone therapy for alopecia areata. J Am Acad Dermatol 1999: 40: 110-112.
14. Fieldler V C. Alopecia areata. Arch Dermatol 1992: 128: 1519-1529.
15. Gourgiotou H J, Tosca A et al. Vitiligo as a reaction to topical treatment with diphencyprone. Dermatologica 1988: 177: 146-148.
16. Anon. 'Dyschromia in confetti' as a side effect of topical immunotherapy with diphenylcyclopropenone. Arch Dermatol 1992: 128: 518-520.
17. Perret C M, Steijlen P M, Zaun H, Happle R. Erythema multiforme-like eruptions: a rare side effect of topical immunotherapy with diphenylcyclopropenone. Dermatologica 1990: 180: 5-7.
18. Puig L, Alegre M, Cuatrecasas M, De Moragas J M. Erythema multiforme-like reaction following diphencyprone treatment of plane warts. Int J Dermatol 1994: 33: 201-203.